Position in AMGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,718,435
+$88,432 QoQ
Shares Held
4,884
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $69,112,010 across 15 Drug Manufacturers - General names. AMGN ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,612 | $21,415,877 | |
| 2 | ABBV |
AbbVie Inc.
|
87,821 | $19,100,189 | |
| 3 | LLY |
ELI LILLY & Co
|
13,180 | $12,122,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,472 | $7,875,626 | |
| 5 | PFE |
Pfizer Inc
|
87,568 | $2,458,909 | |
| 6 | GSK |
GSK plc
|
33,440 | $1,845,553 | |
| 7 | AMGN |
Amgen Inc
This page
|
4,884 | $1,718,435 | |
| 8 | NVS |
Novartis AG
|
6,726 | $1,027,396 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,718,435 | 4,884 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,630,003 | 4,980 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $1,404,227 | 4,976 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,379,855 | 4,942 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $1,445,903 | 4,641 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,688,425 | 6,478 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,958,392 | 6,078 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $1,940,626 | 6,211 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $1,712,743 | 6,024 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,470,630 | 5,106 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $1,422,815 | 5,294 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $1,211,563 | 5,457 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $1,389,095 | 5,746 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $1,748,394 | 6,657 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $1,352,174 | 5,999 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $1,466,125 | 6,026 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $1,522,256 | 6,295 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $1,414,161 | 6,286 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $1,509,602 | 7,099 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $2,014,837 | 8,266 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $2,112,645 | 8,491 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $1,606,221 | 6,986 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $1,782,169 | 7,012 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $1,643,472 | 6,968 | Shares | Sole | 2024-01-02 | |
| 2020-03-31 | $1,387,281 | 6,843 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||